• Svenska
  • English
Toleranzia - Logotype
  • Start
  • About us
    • Operations
    • Board of Directors
    • Management
    • Team
    • Collaboration
    • Career
  • Technology
    • Tolerogens
  • Program
    • Autoimmune disease
    • Rare disease
    • Myasthenia Gravis
    • SME Instrument
    • Pipeline
  • News
    • All press releases
    • Events
    • Media
  • Investors
    • Rights Issue 2023
    • Reports
    • Corporate governance
    • Share information
    • Investor Relations
  • Contact
  • Share price:
  • Latest: (SEK)  
  • High: (SEK)  
  • Nasdaq
  • Toleranzia - Twitter

News

  • All press releases
  • Events
  • Media

Press releases

9 May - 2023

Notice of Annual General Meeting of Toleranzia AB (publ)

The shareholders of Toleranzia AB (publ), 556877-2866, ("Toleranzia" or the "Company"), are hereby invited to attend...

4 May - 2022

Notice of Annual General Meeting of Toleranzia AB (publ)

The shareholders of Toleranzia AB (publ), 556877-2866, ("Toleranzia" or the "Company"), are hereby invited to attend...

10 August - 2021

Notice of extraordinary general meeting of Toleranzia AB (publ)

The shareholders of Toleranzia AB (publ), org.nr 556877-2866 ("Toleranzia" or the "Company"), are hereby convened to...

Subscribe to
Toleranzia’s news here

Toleranzia AB

Arvid Wallgrens backe 20, 8th floor
SE-413 46 Göteborg, Sweden

More contact info

© 2015-2023 Toleranzia AB | All rights reserved

plucera webbyrå

  • Start
  • About us
    ▼
    • Operations
    • Board of Directors
    • Management
    • Team
    • Collaboration
    • Career
  • Technology
    ▼
    • Tolerogens
  • Program
    ▼
    • Autoimmune disease
    • Rare disease
    • Myasthenia Gravis
    • SME Instrument
    • Pipeline
  • News
    ▼
    • All press releases
    • Events
    • Media
  • Investors
    ▼
    • Rights Issue 2023
    • Reports
    • Corporate governance
    • Share information
    • Investor Relations
  • Contact